Trial Profile
Clinical Outcome of Delayed or Standard Prograf Together with Induction Therapy Followed by Conversion to Advagraf in DCD Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 21 Jun 2018 New trial record